Exagen Inc. Common Stock
$8.41
$0.54 (+6.86%)
$7.87Day Range$8.42
Key Statistics
Market Cap
$203.74M
Shares Outstanding
24.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 19, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$7.87
Day High
$8.42
Day Low
$7.87
Volume
351.7K
VWAP
$8.26
Prev Close
$7.87
Transactions
--
Acc. Volume
--
About Exagen Inc. Common Stock
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
SERVICES-MEDICAL LABORATORIESSIC 8071220 employees1261 LIBERTY WAY, VISTA, CA, 92081(760) 560-1501IPO Sep 19, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001274737
- Composite FIGI
- BBG00178FZY1
- Share Class FIGI
- BBG001TCQVF6
- Ticker Root
- XGN
- SIC Code
- 8071
About Exagen Inc. Common Stock (XGN) Stock
Exagen Inc. Common Stock (XGN) closed the 2026-09-18 session at $8.41, up 6.86% versus the previous close (+0.54). The stock opened at $7.87 and traded between $7.87 and $8.42 during that session. Session trading volume was 352K shares. The volume-weighted average price (VWAP) is $8.26.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Exagen Inc. Common Stock has a market capitalization of $203.7 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. XGN is listed on the XNAS exchange. The company employs approximately 220 people. Exagen Inc. Common Stock is headquartered in VISTA, CA. The recorded listing date is 2019-09-19.
On this page you can find market XGN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.